Compare Cardinal Health Inc (CAH) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs TeraWulf Inc — how do they compare? Cardinal Health Inc trades at $228.56 (market cap $53.89B), while TeraWulf Inc trades at $19.56 (market cap $9.61B). The key difference: Cardinal Health Inc is far larger — about 5.6× TeraWulf Inc's market cap, and Cardinal Health Inc pays a 0.89% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals.
| CAH | WULF | |
|---|---|---|
Market Cap | $53.89B | $9.61B |
Sector | Health | Technology |
52-Week High | $239.71 | $28.98 |
52-Week Low | $146.04 | $4.76 |
Enterprise Value | $58.87B | $12.30B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
WULF trades at $20.89, down 4.92% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $661.42 million in 2025, with revenue of $168.46 million, but secured a significant 20-year, $19 billion AI infrastructure deal with Anthropic, driving positive analyst sentiment. Key support lies at $20, with resistance at $21.
The outlook hinges on execution of the Anthropic partnership, offering substantial growth potential, but high valuation ratios and persistent losses pose risks. Analyst consensus is strongly bullish with a $35.40 price target, though operational cash flow remains negative. Investors face volatility from execution delays and competitive pressures in AI infrastructure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
